Indication

Dacryocystitis

**Dacryocystitis** is an inflammation or infection of the lacrimal sac, which forms part of the ocular tear drainage system. Read more about Dacryocystitis

48 drugs 27 manufacturers

Advertisement

Drugs that treat it

Common Dacryocystitis therapies.

Showing 28–36 of 48 drugs

TOBRAMYCIN

KERATOCONJUNCTIVITIS·+5
Bausch Health US

TOBRAMYCIN

OPHTHALMIC ANTIBACTERIALS·KERATOCONJUNCTIVITIS·+5
ALEMBIC PHARMAC

TOBRAMYCIN

OPHTHALMIC ANTIBACTERIALS·KERATOCONJUNCTIVITIS·+5
Pfizer Laboratories
Filter & compare in the drug finder →Opens the drug finder with Dacryocystitis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Dacryocystitis.

**Dacryocystitis** is an inflammation or infection of the lacrimal sac, which forms part of the ocular tear drainage system.

It most frequently develops secondary to an obstruction within the nasolacrimal duct, leading to the stagnation of tears and subsequent colonization, predominantly by bacterial pathogens such as *Staphylococcus* and *Streptococcus* species.

The condition can occur at any age but is most commonly observed in infants due to congenital duct anomalies and in older adults due to age-related ductal stenosis.

Defining clinical features include pain, erythema, warmth, and marked swelling over the medial canthus and lacrimal fossa, often accompanied by epiphora and expressible purulent discharge from the puncta.

Personalize your experience

Follow Dacryocystitis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it